The company said initial efficacy results from a Phase I trial did not provide a competitive benefit-risk profile in CLDN18.2-positive gastric and gastroesophageal cancer.
NEW YORK – Everest Medicines said on Sunday that the US Food and Drug Administration cleared an investigational new drug application (IND) seeking permission to begin studying its mRNA vaccine EVM14 ...
The firm's Heart-2 study of VERVE-102, which is designed to inactivate the PCSK9 gene, is already underway in Canada and the UK.
Alnylam's RNAi TTR Silencing Drug Amvuttra FDA Approved for Transthyretin Amyloidosis Cardiomyopathy
The drug was already sold for TTR amyloidosis with polyneuropathy, and now is available to patients with hereditary or wild-type ATTR-CM.
Precision Medicine Online's 2024 survey shows biomarker test expansion but low clinical trial enrollment and long wait times ...
NEW YORK – The US Food and Drug Administration on Friday approved Telix's PSMA-PET prostate cancer imaging agent Gozellix (gallium-68 gozetotide injection) to identify PSMA-positive prostate cancer ...
NEW YORK – Angle on Friday said it is seeking to engage with BlissBio Biopharmaceutical to develop the antibody-drug conjugate BB-1701 alongside its circulating tumor cell (CTC) assay, following Eisai ...
The firm's stock price dropped 27 percent on Tuesday following the news that the young man died from acute liver failure after getting Elevidys.
An intravenous form of the gene therapy is already approved and sold as Zolgensma in the US for patients less than 2 years of age.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback